Outcome of Ablation of Tachyarrhythmias in Patients With Congenital Heart Diseases
1 other identifier
observational
40
1 country
1
Brief Summary
Our observational study aim to to evaluate the incidence of Tachyarrhythmia in patients with congenital heart diseases (corrected/non corrected) and the effectiveness of catheter ablation.RF catheter ablation was performed to all patients and follow up for recurrence was done for one year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedFirst Submitted
Initial submission to the registry
April 21, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedMay 8, 2026
April 1, 2024
11 months
April 21, 2026
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
the rate of acute success of catheter ablation
defined as termination of the clinical arrhythmia with non-inducibility of this clinical arrhythmia during Catheter ablation
From timing of catheter ablation till about one hour
rate of recurrence of tachyarrhythmias after catheter ablation
one year
Secondary Outcomes (1)
The types of Tachyarrhythmia in patients with congenital heart diseases
One year
Study Arms (1)
Patients with congenital heart diseases with arrhythmia
Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia or without documented arrhythmia but frequent palpitations.
Eligibility Criteria
patients with congenital heart diseases (corrected / non corrected) with arrhythmia
You may qualify if:
- Patients with congenital heart diseases (corrected / non corrected) with documented arrhythmia
- Patients with congenital heart diseases without documented arrhythmia but frequent palpitations.
You may not qualify if:
- Pregnant
- Patients with unstable hemodynamics
- End stage diseases e.g.: cancer stage IV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cairo university hospitals
Cairo, 11956, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Critical Care Medicine
Study Record Dates
First Submitted
April 21, 2026
First Posted
May 8, 2026
Study Start
April 16, 2024
Primary Completion
February 26, 2025
Study Completion
February 28, 2026
Last Updated
May 8, 2026
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share